Radioimmunohistochemistry of epidermal growth factor receptor in breast cancer

Archives of Pathology and Laboratory Medicine

Volumn 126, Issue 2, 2002, Pages 177-181

  Robertson, Kevin W ^a   Reeves, Jonathon R ^a   Lannigan, Alison K ^a   Going, James J ^a   Cooke, Timothy G ^a   Stanton, Peter D ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HISTOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RADIOIMMUNOHISTOCHEMISTRY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; MIDDLE AGED; RADIOLIGAND ASSAY; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0036171201     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Epidermal, growth factor receptors and estrogen receptors in human breast cancer
2. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients
3. The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients
4. Expression of epidermal growth factor receptor and C-erbB-2 oncoprotein in human tumors
5. Epidermal growth factor receptors in human breast cancer: A plea for standardisation of assay methodology
6. Detailed methodologies of the development of assays for growth factors and growth factor receptors
7. Immunohistochemical assay for epidermal growth factor receptor on paraffin-embedded sections: Validation against ligand binding assay and clinical relevance in breast cancer
8. Sources of variation in the assessment of cell proliferation using proliferating cell nuclear antigen immunohistochemistry
9. Reproducibility of subjective immunostaining of steroid receptors in breast cancer
10. Epidermal growth factor receptor-negative tumours are predominantly confined to the sub-group of estradiol receptor-positive human primary breast cancers
11. Quantitative radio-immunohistochemical measurements of c-erbB-2 receptors in frozen tissue sections
12. Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenographs
13. Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer
14. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding
15. Hydroxyapatite assay to measure epidermal growth factor receptor in human primary breast tumors
16. LIGAND: A computerised analysis of ligand binding data
17. Monoclonal antibody to the human epidermal growth factor receptor
18. Localisation of EGF receptors in frozen tissue sections by antibody and biotinylated EGF-based techniques
19. Human squamous cell lung cancers express increased epidermal growth factors
20. Epidermal growth factor receptors in breast cancer: Comparison of radioligand and immunocytochemical assays
21. A comparison of biochemical and immunohistochemical assessment of EGFR expression in ovarian cancer
22. Comparison of radioligand assay and immunostaining for epidermal growth factor receptor in human breast cancer
23. Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of oestradiol receptor positive human primary breast cancers
24. Heterodimerisation and functional interaction between EGF receptor family members: A new signalling paradigm with implications for breast cancer research
25. Evaluation of flow-cytometric three-parameter analysis for EGFR quantification and DNA assessment in human bladder cancers
26. HPR-2 overexpression, and intratumor heterogeneity in human breast cancer
27. Epidermal growth factor receptor in breast cancer: Comparison with non malignant breast tissue
28. Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach
29. Human breast cancer: Correlation of relapse and survival with amplification of the HER2/neu proto-oncogene in human breast and ovarian cancer
30. Role of epidermal growth factor receptor expression in primary breast cancer: Results of a biochemical study and an immunocytochemical study
31. Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: Evidence for down-regulation in cervical cancer
32. EGF cell surface receptor quantitation on ocular cells by an immunocytochemical flow cytometry technique
33. Cell kinetics in vivo of human breast cancer